Success Stories: EB-1A Approved for a Lab Specialist in Utah in the Field of Pharmacy

Client’s Testimonial:

 

Thank you very much for an efficient and professional handling of my case.
 


We Received EB1-A (Alien of Extraordinary Ability) Approval on July 17th, 2014 for a Lab Specialist in Utah in the Field of Pharmacy (Approval Notice)


General Field: Pharmacy

Position at the Time of Case Filing: Lab Specialist

Country of Origin: India

Service CenterNebraska Service Center (NSC)

State of Residence at the Time of Filing:  Utah

Approval Notice Date: July 17, 2014

Processing Time: 2 Months, 8 Days (including time to respond to RFE, Premium Processing requested)

 

 


Case Summary:

In this case, the client that we had the pleasure of working with was a Lab Specialist in Utah in the field of Pharmacy. His specialized research has focused on improving our understanding of a fibro-proliferative disorder known as keloid scarring, which is known to cause considerable functional and aesthetic problems in humans, by identifying previously unknown molecular mechanisms. His work had resulted in 18 peer-reviewed scientific articles, numerous presentations at national and international conferences, and 9 published abstracts. At the time that his case was filed, his publications had been cited at least 436 times by researchers around the world, serving as apparent and objective evidence of his major influence and impact on the field of endeavor, in addition to his sustained international acclaim. He had also conducted 9 manuscript reviews for 5 distinctive, internationally circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “His work has been remarkably beneficial to the international community of cancer researchers, as he has the unique dual abilities of elucidating novel molecular mechanisms of complex pathways in addition to formulating and assessing potential treatments against these pathways.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmacy, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 2 months and 8 days.